Tag: GE

Fraud – A Sign of The Times

Fraud – A Sign of The Times

Fraud always spikes during frothy markets. If it feels like we are beating you over the head as it relates to Quality CEOs and CEO Integrity it is because we are. High Quality, High Integrity CEOs are the best preventive measure against getting burned by fraudulent companies. 2020 has delivered massive equity market valuation froth … Continue reading Fraud – A Sign of The Times

Institutional Investors Forgot They Have A Voice. PLUS – Big Tech Regulation.

Institutional Investors Forgot They Have A Voice. PLUS – Big Tech Regulation.

It is amazing what institutional investors - especially large holders - put up with. Do Portfolio Managers communicate with CEOs any longer? PMs used to speak with management teams to provide feedback around capital allocation decisions, financial disclosures and more. My sense is that less of this interaction occurs today. Below we cover a few … Continue reading Institutional Investors Forgot They Have A Voice. PLUS – Big Tech Regulation.

Carlos Brito Is On His Way Out as BUD CEO. Did BUD’s Board Try To Help Brito?

Carlos Brito Is On His Way Out as BUD CEO. Did BUD’s Board Try To Help Brito?

CEO's need to be comfortable with some level of diversification to keep their companies relevant over the long-term. Long-time Anheuser-Busch InBev (ticker: BUD) CEO Carlos Brito was not afraid of big acquisitions. However, his most notable large acquisitions (Anheuser-Busch and SABMiller) failed to add new beverage categories to the tired product portfolio while weighting it … Continue reading Carlos Brito Is On His Way Out as BUD CEO. Did BUD’s Board Try To Help Brito?

GE’s BioPharma Deal Is at Risk

GE’s BioPharma Deal Is at Risk

We 100% disagree with Barron's that General Electric's deal to sell its BioPharma business to Danaher (tkr: DHR), for $21.4 billion (original deal announced February 2019), should close soon. This is precisely the type of large deal struck at a peak market that will either get delayed indefinitely or negotiated down. Danaher has the upper … Continue reading GE’s BioPharma Deal Is at Risk

Toxic Long Term Care Policies: A Bane for Many. A Boon for Some.

Toxic Long Term Care Policies: A Bane for Many. A Boon for Some.

Some years ago many insurance carriers wrote tranches of long-term care (“LTC”) life insurance policies which have proved to be toxic. These “toxic” LTC policies - primarily written between 1999-2004 - were at the heart of a scathing critique of General Electric (tkr: GE) last week which ultimately accused the company of accounting fraud. While … Continue reading Toxic Long Term Care Policies: A Bane for Many. A Boon for Some.

Boards: Perform Due Diligence on CEO Candidates Upfront. GE Is Still Cleaning Up Its Mess.<span class="badge-status" style="background:red">Premium</span> 

Boards: Perform Due Diligence on CEO Candidates Upfront. GE Is Still Cleaning Up Its Mess.Premium 

I’m puzzled by the mess that is GE. The Company recently removed former CEO John Flannery after only 14 months at the helm only to replace him with a Board member (Larry Culp). I was a fan of Flannery’s effort to decentralize operations and to divest non-strategic businesses. However, I did not agree with all … Continue reading Boards: Perform Due Diligence on CEO Candidates Upfront. GE Is Still Cleaning Up Its Mess.Premium 

GE & Air Immelt – Have A Fleet of Planes – So Long as You Are Outperforming

Below is a post I wrote late last night and published to LinkedIn under CEORater. The post was in response to a Wall Street Journal article published about the use of an executive jet by former GE CEO Jeff Immelt which was not reported to the company's Board. Short story is that too much is … Continue reading GE & Air Immelt – Have A Fleet of Planes – So Long as You Are Outperforming